Clinical Trial Update: Minocycline for HIV+ Cognitive Impairment in Uganda [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating minocycline for HIV-associated neurocognitive disorder was terminated; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hiv-associated Neurocognitive Disorder

Drugs mentioned

• Minocycline (minocycline)

Snippet

Sponsor: Johns Hopkins University | Conditions: HIV-associated Cognitive Impairment, HIV Infections | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2011-02-25